Grand Challenge

Cancer Research UK's Grand Challenge is the most ambitious cancer research initiative in the world: a series of £20m awards seeking international, multidisciplinary teams willing to take on the toughest challenges in cancer, and providing the freedom to try novel approaches, at scale. To date, we’ve funded 7 teams across 9 countries representing an investment of up to £130m over the next 5 years.

We asked the international research community to help us shape the next round of Grand Challenge: over the course of 5 months in 2019, we held challenge-setting workshops in Madrid, Milan, Edinburgh, London and Amsterdam, and gathered challenge ideas from the wider research community. Our Grand Challenge Advisory Panel, chaired by Sir Paul Nurse, will consider the outputs and select the next round of challenges.

We’ll reveal the next round of Grand Challenges in February 2020 – get ready to apply.

2019

Consultation 

We seek input to help shape the next round of Grand Challenge. 

July 2020

Express Interest

Collaborators open their application outlining their proposed team and approach

Oct 2020

Shortlist

Expressions of interest are reviewed and selected teams receive seed-funding to develop full applications

Feb 2021

Full Application

Shortlisted teams submit full applications and are interviewed by the independent advisory panel

Sep 2021

Award

Winning teams awarded up to £20 million over 5 years to conduct their pioneering research

2019 funded teams

Understanding why cancers grow in some tissues and not in others

Professor Elledge's team want to generate a comprehensive map of cancer drivers and their specificity to different tissues. This has the potential to improve our basic understanding of cancer, and provide information that will impact therapeutic choices for patients.

A new way to tackle inflammation-associated cancer

Professor Tlsty's team want to find novel ways of treating cancer that has been caused by inflammation, and develop new options to prevent cancer developing in high-risk patients with chronic inflammatory diseases.

Manipulating the microbiome to beat bowel cancer

Professors Meyerson and Garrett's team want to discover exactly how certain microbes inside the body lead to cancer development and influence a patient’s response to treatment.  

Our partners

Grand Challenge is funded through the generosity of supporters and our partners. In the first round we partnered with the Dutch Cancer Society to co-fund the Grand Challenge team led by Prof. Jelle Wesseling. We are excited to announce that this round we are partnering with The Mark Foundation for Cancer Research to co-fund Prof. Steve Elledge's Grand Challenge team. 

Rate this page:

Currently rated: 4.2 out of 5 based on 26 votes
Thank you!
We've recently made some changes to the site, tell us what you think